Mst1 deletion rescued the metabolic NAFLD signature phenotypes, namely body weight, blood glucose levels, triglycerides levels, total cholesterol and levels of lipid metabolism enzymes (Zhou T. et al., 2019). This evidence concerns the gene MST1 and metabolic dysfunction-associated steatotic liver disease.